These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22097429)

  • 1. [Erectile dysfunction. Another option].
    Sabourin G
    Perspect Infirm; 2011; 8(6):56. PubMed ID: 22097429
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of erectile dysfunction].
    Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2010 Sep; 39(5):385-90. PubMed ID: 20818688
    [No Abstract]   [Full Text] [Related]  

  • 3. Newer phosphodiesterase inhibitors: comparison with established agents.
    McNamara ER; Donatucci CF
    Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction.
    Limin M; Johnsen N; Hellstrom WJ
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1427-37. PubMed ID: 20939743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexually transmitted infection in HIV-positive men with erectile dysfunction using phosphodiesterase-5 inhibitors.
    McCarty EJ; Quinn K; Dinsmore WW
    Sex Transm Infect; 2011 Oct; 87(6):455. PubMed ID: 21764891
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors.
    Liu DF; Jiang H; Hong K; Zhao LM; Tang WH; Ma LL
    Chin Med J (Engl); 2010 Nov; 123(22):3258-61. PubMed ID: 21163126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of erectile dysfunction after radical prostatectomy].
    Radnaev LG; Govorov AV; Pushkar' DIu
    Urologiia; 2010; (4):75-9. PubMed ID: 20967987
    [No Abstract]   [Full Text] [Related]  

  • 8. Erectile dysfunction and hypogonadism (low testosterone).
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():2-7. PubMed ID: 21501544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insurance coverage for erectile dysfunction drugs.
    Hornbrook MC; Holup J
    Clin Pharmacol Ther; 2011 Jan; 89(1):19-21. PubMed ID: 21170065
    [No Abstract]   [Full Text] [Related]  

  • 10. A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases.
    Chung E; Broc GB
    Expert Opin Pharmacother; 2011 Jun; 12(8):1341-1348. PubMed ID: 21548725
    [No Abstract]   [Full Text] [Related]  

  • 11. Brachial artery flow mediated assessment: a tool to predict the response to chronic PDE5 inhibition with tadalafil in patients with erectile dysfunction.
    Mancini M; Guazzi M; Bianco E; Colpi GM
    Int J Cardiol; 2011 Feb; 146(3):471-2. PubMed ID: 21194760
    [No Abstract]   [Full Text] [Related]  

  • 12. Complementary medicine and erectile dysfunction: will you accept the charges?
    Jackson G
    Int J Clin Pract; 2011 Mar; 65(3):231. PubMed ID: 21314857
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlations with satisfaction measures in men treated with phosphodiesterase inhibitors for erectile dysfunction.
    Mulhall JP; Kaminetsky JC; Althof SE; Goldstein I; Creanga DL; Marfatia A; Symonds T; Budhwani M
    Am J Mens Health; 2011 May; 5(3):261-71. PubMed ID: 21406491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nitrates and PDE5 inhibitors: pharmaceutical care].
    Ude M; Ude C; Leuner K
    Pharm Unserer Zeit; 2010 Sep; 39(5):397-404. PubMed ID: 20818690
    [No Abstract]   [Full Text] [Related]  

  • 15. Which drug for erectile dysfunction? There are some potentially helpful differences between these medications, but price can limit your choices.
    Harv Mens Health Watch; 2014 Jun; 18(11):6-7. PubMed ID: 25029709
    [No Abstract]   [Full Text] [Related]  

  • 16. [ Editorial. Pharmazie in unserer Zeit 5/2010].
    Dingermann T; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2010 Sep; 39(5):331. PubMed ID: 20818677
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatments for erectile dysfunction in spinal cord lesioned patients. Are there alternatives to phosphodiesterase type 5 inhibitors?
    Wyndaele JJ
    Spinal Cord; 2015 Dec; 53(12):841. PubMed ID: 26634316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of self-esteem in males with erectile dysfunction treated with viagra. Analysis of a Spanish patients group selected from a multicenter, international study].
    Martínez-Jabaloyas JM; Moncada I; Rodríguez-Vela L; Gutiérrez PR; Chaves J
    Actas Urol Esp; 2010 Sep; 34(8):699-707. PubMed ID: 20800034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do men with mild erectile dysfunction have the same risk factors as the general erectile dysfunction clinical trial population?
    Lee JC; Bénard F; Carrier S; Talwar V; Defoy I
    BJU Int; 2011 Mar; 107(6):956-60. PubMed ID: 20950304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Zhao C; Kim SH; Lee SW; Jeon JH; Kang KK; Choi SB; Park JK
    BJU Int; 2011 Jun; 107(12):1943-7. PubMed ID: 21054754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.